| Dr Kenneth John Ortiz, MD | |
|
620 John Paul Jones Cir, Nmcp- Plastic Surgery, Portsmouth, VA 23708-2111 | |
| (757) 952-2883 | |
| (757) 953-0851 |
| Full Name | Dr Kenneth John Ortiz |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942377924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 046706 (Georgia) | Secondary |
| 208200000X | Plastic Surgery | 0101266620 (Virginia) | Primary |
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.
A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most commonly used therapy, according to a University of Cincinnati researcher.
Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.
Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen.
Professor James Wilkinson at the University of Southampton's Optoelectronics Research Centre has been awarded a European Research Council (ERC) Advanced Grant to realise tools for fast, low-cost point-of-care clinical diagnostics and for chemical analysis in water pollution and food safety.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth John Ortiz, MD 508 Piping Rock Dr, Chesapeake, VA 23322-8894 Ph: (757) 953-2883 | Dr Kenneth John Ortiz, MD 620 John Paul Jones Cir, Nmcp- Plastic Surgery, Portsmouth, VA 23708-2111 Ph: (757) 952-2883 |
News Archive
National University of Singapore researchers at the Faculty of Engineering's Department of Bioengineering have discovered a new technology that paves the way for a new safe and non-invasive method of treating deep cancer. Led by Associate Professor Zhang Yong, the team has so far, proven that their technology could inhibit tumour growth and control gene expression in mice. This is a world's first for the use of nanoparticles for non-invasive photodynamic therapy of deep cancer.
A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most commonly used therapy, according to a University of Cincinnati researcher.
Medtronic Inc.,and Osteotech, Inc.,today announced that the companies have signed a definitive agreement under which Medtronic will acquire Osteotech for $6.50 per share in cash for each share of Osteotech common stock. The total value of the transaction is expected to be approximately $123 million.
Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen.
Professor James Wilkinson at the University of Southampton's Optoelectronics Research Centre has been awarded a European Research Council (ERC) Advanced Grant to realise tools for fast, low-cost point-of-care clinical diagnostics and for chemical analysis in water pollution and food safety.
› Verified 9 days ago
Dr. Mark Pieter Honig, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: Naval Medical Center, Portsmouth, 3 Effingham Street, Portsmouth, VA 23708 Phone: 757-953-2883 | |
Dr. Robert Eugene Hersh, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-7550 Fax: 757-953-0851 |